U.S. Pharma Stock News

Earnings shock and governance changes put KE Holdings in focus KE Holdings (BEKE) has drawn fresh attention after reporting a sharp drop in net income to RMB432 million from RMB2,750 million, along with steep pressure in new home transaction services and rising concerns about China’s housing market recovery. See our latest analysis for KE Holdings. The stock’s recent 1 month share price return of 17.89% and 7 day gain of 8.92%, against a 1 year total shareholder return decline of 14.91% and a...

Tenable Holdings (TENB) is back in focus after first quarter 2026 earnings, where revenue and profitability were ahead of its own expectations and full year guidance for both metrics was raised. See our latest analysis for Tenable Holdings. Despite the upbeat earnings and raised guidance, Tenable’s recent share price performance has been mixed, with a 30 day share price return of 18.5% but a 1 year total shareholder return decline of 33.4%. This suggests that optimism is rebuilding from a...

Fulton Financial (FULT) is back in focus after the bank completed a $300 million fixed to floating rate subordinated notes offering. This refinancing move reshapes its capital structure and long term funding profile. See our latest analysis for Fulton Financial. These refinancing plans and the recent share buyback sit against a mixed price backdrop. The 1 month share price return is 3.26%, but there has been a 1 day decline of 1.94%. Meanwhile, the 1 year total shareholder return of 29.03%...

Synchrony Financial (SYF) just packed several shareholder focused moves into one stretch, reporting higher first quarter net income along with new co-branded card partnerships, a planned dividend increase, and a multi billion dollar buyback program. See our latest analysis for Synchrony Financial. Despite the flurry of new partnerships with Lowe's and Chico's FAS and the earnings update, Synchrony Financial's recent trading has been mixed. The 1 month share price return is 8.51% but the year...

Rev8 launch puts Ouster’s technology shift in focus Ouster (OUST) has drawn fresh attention after launching its Rev8 OS digital lidar sensors, built on its new L4 Ouster Silicon and introducing native color lidar with up to double the prior range and resolution. With orders already open and shipments starting this quarter, the Rev8 family targets automotive, industrial, robotics, and smart infrastructure uses, giving investors a concrete product milestone to watch as adoption by major...

PureCycle Technologies (PCT) is back in focus after Plastic Ingenuity adopted its PureFive resin for coffee lid production, bringing recycled polypropylene into a high volume, food contact packaging use case. See our latest analysis for PureCycle Technologies. The Plastic Ingenuity deal arrives after a volatile stretch for PureCycle, with a 35.61% 1 month share price return offset by a 25.53% 3 month share price decline and a 17.88% year to date share price fall. At the same time, the 1 year...

Twist Bioscience recently reported past second-quarter 2026 results, with sales rising to US$110.72 million from US$92.79 million a year earlier, while net loss widened to US$44.02 million and loss per share increased to US$0.71. Alongside earnings, Twist launched its Complex Genes offering, a step that materially broadens its ability to synthesize highly engineered, difficult-to-manufacture DNA sequences for advanced therapeutics and AI-driven drug discovery. Next, we’ll examine how the...

NVR (NVR) stock is back in focus after first quarter 2026 results showed lower profit and revenue, weaker homebuilding margins, and a drop in settlements, with earnings missing analyst expectations and pressuring sentiment. See our latest analysis for NVR. The weaker first quarter results and earnings miss have gone hand in hand with a 23.66% 90 day share price return decline and a 16.17% fall in 1 year total shareholder return, suggesting momentum has cooled after a modest 3 year gain. If...

In late April 2026, Constellium SE reported first‑quarter sales of US$2.46 billion and net income of US$199 million, with earnings per share from continuing operations rising sharply year on year and record Adjusted EBITDA prompting higher full‑year 2026 guidance and a new US$300 million share repurchase program. Alongside this strong start to 2026, Constellium secured a multi‑year aluminum extrusions supply agreement with Airbus and saw mixed insider activity, combining sizeable share sales...

IMAX (IMAX) surprised the market with first quarter earnings per share above analyst expectations, even as revenue softened. The company also reaffirmed its guidance for record 2026 box office and outlined early second quarter strength. See our latest analysis for IMAX. The latest earnings beat and reaffirmed box office guidance come as the stock has cooled in the short term, with a 1-month share price return of a 12.19% decline and a year-to-date share price return of a 2.17% decline. At the...

Cisco Systems (CSCO) has drawn fresh attention after unveiling its Universal Quantum Switch, a research prototype designed to route and convert quantum information across major encoding methods at room temperature on standard telecom fiber. See our latest analysis for Cisco Systems. That quantum networking announcement comes at a time when momentum in Cisco’s stock has clearly picked up, with a 30 day share price return of 17.22% and a 1 year total shareholder return of 59.75% reinforcing a...

WSFS Financial (WSFS) just packed several shareholder focused moves into one update, pairing first quarter results with an 18% dividend increase and a sizable new share repurchase authorization that reframes the stock’s current appeal. See our latest analysis for WSFS Financial. Despite a 1 day share price decline of 1.28% to US$71.21 and a slightly weaker 7 day share price return, WSFS still carries strong momentum. The company has a 29.36% year to date share price return and a 35.84% 1 year...

Tennant (TNC) is back in focus after Q1 2026 results showed sales of US$297.9 million and non-GAAP EPS ahead of analyst expectations, alongside a larger share repurchase capacity of up to 15%. See our latest analysis for Tennant. At a share price of US$81.95, Tennant has seen a 17.34% 1 month share price return and a 10.80% year to date share price return. The 1 year total shareholder return of 16.32% points to building momentum as investors weigh Q1 earnings, the expanded buyback capacity...

Analyst Concerns and Dividend Move Put Tencent Music in Focus Recent analyst downgrades and slightly reduced fair value estimates have pushed Tencent Music Entertainment Group (TME) into the spotlight, as competition and earnings visibility stay front of mind for investors. At the same time, the company’s ordinary annual cash dividend of US$0.12 per share for 2025, with an ex dividend date of 1 April 2026, offers a degree of income continuity that some shareholders may welcome. See our latest...

In late April 2026, Nuvalent announced a multi-year collaboration with Guardant Health to use Guardant’s Infinity tissue and liquid biopsy platform to support clinical development, potential companion diagnostics, and future global commercialization of Nuvalent’s oncology pipeline. This partnership reinforces how precision diagnostics are becoming integral to drug development, tying Guardant’s testing capabilities directly to emerging targeted cancer therapies and potential regulatory...

Commvault Systems recently reported fourth-quarter 2026 revenue of US$311.69 million and full-year revenue of US$1.18 billion, issued fiscal 2027 guidance calling for US$1.30–US$1.31 billion in total revenue, completed a major share repurchase program, and expanded its Commvault Cloud platform availability to Google Cloud Marketplace. These developments, alongside growing annual recurring revenue and upcoming presentations at Google Cloud Next 2026 and the GEOINT Symposium 2026, highlight...

In April 2026, DuPont’s Corian Design business introduced its 2026 “Nature in Motion” Color Collection for solid surface and quartz, while its Liveo unit launched Pharma TPE Overmolded Assemblies designed to support ultrapure fluid transfer in pharmaceutical and biopharmaceutical manufacturing. By broadening both its design-centric surfacing portfolio and its biopharma processing solutions, DuPont is emphasizing material innovation tailored to architects, designers, and life sciences...

Q1 earnings put Pinnacle West Capital (PNW) back in focus Pinnacle West Capital (PNW) is back on investors’ radar after first quarter 2026 results showed sales of US$1,149.6 million and net income of US$32.92 million, compared with a loss in the prior year period. See our latest analysis for Pinnacle West Capital. The Q1 return to profitability and the recently affirmed quarterly dividend of US$0.91 per share have come alongside a 15.52% year to date share price return and a 44.72% three year...

Smurfit Westrock Plc recently reported past first-quarter 2026 results showing sales of US$7,712 million, broadly flat year-on-year, while net income dropped to US$65 million and earnings per share fell to US$0.12. Despite the sharp profit compression and operational challenges, the company affirmed a quarterly dividend of US$0.4523 per share and outlined mill and site closures alongside a review of its London Stock Exchange listing. We’ll now examine how the sharp drop in quarterly profit...

ICU Medical stock snapshot after recent share performance ICU Medical (ICUI) has drawn fresh attention after a weak run in the stock, with negative returns over the past week, month and past 3 months, focusing investors on how its fundamentals compare with recent price action. See our latest analysis for ICU Medical. At a share price of $118.67, ICU Medical has experienced short-term share price pressure, with a 21.25% decline over three months contributing to a 5-year total shareholder...

Deluxe (DLX) has moved into focus after announcing a partnership with MRI Software that makes it the official processing partner for MRI’s rent payment solution, expanding its role in property management payments. See our latest analysis for Deluxe. The new MRI partnership and recent technology awards come on top of strong share price momentum, with a 30-day share price return of 12.69% and a 1-year total shareholder return of 118.64%. However, the 5-year total shareholder return of a 13.84%...

Matson stock moves and recent performance snapshot Matson (MATX) has caught investor attention after recent share price moves, with the stock showing mixed short term returns but gains over the past month, past 3 months, year to date and past year. See our latest analysis for Matson. Recent trading has been choppy, with a 1 day share price return of a 1.57% decline and a 7 day share price return of a 3.34% decline. However, the 30 day and year to date share price returns of 2.67% and 38.09%...

Lazard, Inc. has already reported first‑quarter 2026 results, with net income rising to US$100.92 million and diluted EPS from continuing operations at US$0.91, alongside affirming a US$0.50 per‑share quarterly dividend and continuing a buyback program. Beyond the headline figures, the quarter highlighted a contrast between strong revenue and asset management inflows and an adjusted earnings miss versus analyst expectations, raising fresh questions about cost discipline and earnings...

On 4 May 2026, BioCryst Pharmaceuticals announced it had licensed European commercialization rights for its investigational HAE therapy navenibart to an Irish affiliate of Neopharmed Gentili in exchange for a US$70,000,000 upfront payment, up to US$275,000,000 in potential milestones, and tiered royalties of 18% to 30% on net sales. This agreement deepens BioCryst’s existing relationship with Neopharmed Gentili, uses an established European rare-disease infrastructure, and brings in fresh...